{"cik":1176309,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"ORAMED PHARMACEUTICALS INC.","units":{"USD":[{"start":"2010-09-01","end":"2011-08-31","val":263999,"accn":"0001178913-12-003413","fy":2012,"fp":"FY","form":"10-K","filed":"2012-12-12","frame":"CY2011"},{"start":"2002-04-12","end":"2012-08-31","val":2049406,"accn":"0001178913-12-003413","fy":2012,"fp":"FY","form":"10-K","filed":"2012-12-12"},{"start":"2011-09-01","end":"2012-08-31","val":172470,"accn":"0001178913-12-003413","fy":2012,"fp":"FY","form":"10-K","filed":"2012-12-12"},{"start":"2011-09-01","end":"2012-08-31","val":172470,"accn":"0001178913-13-003442","fy":2013,"fp":"FY","form":"10-K","filed":"2013-11-27","frame":"CY2012"},{"start":"2002-04-12","end":"2013-08-31","val":2421664,"accn":"0001178913-13-003442","fy":2013,"fp":"FY","form":"10-K","filed":"2013-11-27"},{"start":"2012-09-01","end":"2013-08-31","val":372258,"accn":"0001178913-13-003442","fy":2013,"fp":"FY","form":"10-K","filed":"2013-11-27","frame":"CY2013"},{"start":"2023-01-01","end":"2023-12-31","val":4212000,"accn":"0001013762-25-003450","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-27","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":4053000,"accn":"0001013762-25-003450","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-27"},{"start":"2024-01-01","end":"2024-12-31","val":4053000,"accn":"0001213900-26-034835","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024"},{"start":"2025-01-01","end":"2025-12-31","val":5152000,"accn":"0001213900-26-034835","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2025"},{"start":"2026-01-01","end":"2026-06-30","val":469000,"accn":"0001213900-26-087361","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-10"}]}}